Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02664545Not ApplicableActive Not Recruiting

Bridge-Enhanced ACL Repair vs ACL Reconstruction

Role: lead

NCT02292004Not ApplicableActive Not Recruiting

Bridge-Enhanced ACL Repair-Safety Study (BEAR Trial)

Role: lead

NCT03348995Not ApplicableActive Not Recruiting

The BEAR III Trial for Bridge-Enhanced ACL (Anterior Cruciate Ligament) Restoration

Role: lead

NCT05398341Active Not Recruiting

A Prospective Cohort Post Market Registry Evaluating Outcomes of Bridge-Enhanced ACL Restoration (BEAR®)

Role: lead

NCT03776162Not ApplicableActive Not Recruiting

A Comparison of ACL Repair With BEAR Device vs. Autograft Patellar Tendon ACL Reconstruction

Role: collaborator

All 5 trials loaded